TrialJournal of Korean medical science2012

Erythropoietin improves long-term outcomes in patients with acute kidney injury after coronary artery bypass grafting.

Se Won Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.